1. Home
  2. BLRX vs ARKR Comparison

BLRX vs ARKR Comparison

Compare BLRX & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • ARKR
  • Stock Information
  • Founded
  • BLRX 2003
  • ARKR 1983
  • Country
  • BLRX Israel
  • ARKR United States
  • Employees
  • BLRX N/A
  • ARKR N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • ARKR Restaurants
  • Sector
  • BLRX Health Care
  • ARKR Consumer Discretionary
  • Exchange
  • BLRX Nasdaq
  • ARKR Nasdaq
  • Market Cap
  • BLRX 54.1M
  • ARKR 48.2M
  • IPO Year
  • BLRX 2011
  • ARKR N/A
  • Fundamental
  • Price
  • BLRX $0.46
  • ARKR $11.71
  • Analyst Decision
  • BLRX Strong Buy
  • ARKR
  • Analyst Count
  • BLRX 2
  • ARKR 0
  • Target Price
  • BLRX $11.50
  • ARKR N/A
  • AVG Volume (30 Days)
  • BLRX 202.4K
  • ARKR 8.3K
  • Earning Date
  • BLRX 11-18-2024
  • ARKR 08-12-2024
  • Dividend Yield
  • BLRX N/A
  • ARKR 6.37%
  • EPS Growth
  • BLRX N/A
  • ARKR N/A
  • EPS
  • BLRX N/A
  • ARKR N/A
  • Revenue
  • BLRX $17,048,000.00
  • ARKR $184,539,000.00
  • Revenue This Year
  • BLRX N/A
  • ARKR N/A
  • Revenue Next Year
  • BLRX N/A
  • ARKR N/A
  • P/E Ratio
  • BLRX N/A
  • ARKR N/A
  • Revenue Growth
  • BLRX N/A
  • ARKR N/A
  • 52 Week Low
  • BLRX $0.44
  • ARKR $10.27
  • 52 Week High
  • BLRX $1.93
  • ARKR $16.25
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 23.64
  • ARKR 46.48
  • Support Level
  • BLRX $0.50
  • ARKR $11.00
  • Resistance Level
  • BLRX $0.56
  • ARKR $11.99
  • Average True Range (ATR)
  • BLRX 0.05
  • ARKR 0.51
  • MACD
  • BLRX -0.01
  • ARKR 0.03
  • Stochastic Oscillator
  • BLRX 10.60
  • ARKR 42.22

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About ARKR Ark Restaurants Corp.

Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.

Share on Social Networks: